Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee
Program: Abstract Session

Epidemiology, Health Policy, and Outcomes
General Topic: Clinical Science

29W20: Abstracts: Epidemiology & Public Health I (2657–2662)

Wednesday, October 29, 2025
11:30 AM - 1:00 PM Central Time
Location: W184B-C
CE: 0.00

Non-CME In Person On Demand

    Abstract Moderator(s)

  • JG

    Jose A. Gomez-Puerta, MD, PhD, MPH

    Hospital Clínic
    Barcelona, Spain

    Disclosure(s): AbbVie/Abbott: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 30, 2023); AstraZeneca: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Otsuka: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, December 4, 2024); Sanofi: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)

  • VK

    Vivian Kawai, MD

    University of Alabama at Birmingham
    Birmingham, Alabama, United States

    Disclosure information not submitted.

Please note: This session is not eligible for CME Credits.

Presentations:

  • 11:30 AM - 11:45 AM Central Time
    Incidence of Rheumatic Diseases Among Patients Receiving GLP-1 Receptor Agonists: A Comparative Analysis with DPP-4 Inhibitors in a Propensity Score-Matched Cohort

    Presenting Author: Betul Ibis, MD (she/her/hers) – Mount Auburn Hospital/Harvard Medical School

  • 11:45 AM - 12:00 PM Central Time
    Risk of Immune-Mediated Inflammatory Diseases and Other Safety Outcomes in Patients with T2DM and Obesity Initiating GLP-1 RA: A Propensity Score-Matched Multi-center Study using the TriNetX Global Network

    Presenting Author: Hsin-Hua Chen, MD, PhD – Taichung Veterans General Hospital

  • 12:00 PM - 12:15 PM Central Time
    Sodium-Glucose Cotransporter 2 Inhibitors for the Primary Prevention of Systemic Autoimmune Rheumatic Diseases in Patients with Type 2 Diabetes: A Population-Based Target Trial Emulation

    Presenting Author: Jamie Chieh Lo, MD – National Taiwan University Hospital

  • 12:15 PM - 12:30 PM Central Time
    Understanding Gout in Women: Longitudinal Changes in Serum Urate Levels from Pre-menopause through Post-menopause

    Presenting Author: Shreya Billa, BS (she/her/hers) – Brigham and Women's Hospital and Harvard Medical School

  • 12:30 PM - 12:45 PM Central Time
    Heterogeneity of RA-ILD by Longitudinal Forced Vital Capacity Measurements Is Associated with Survival and Respiratory Hospitalization

    Presenting Author: Bryant England, MD, PhD – University of Nebraska Medical Center

  • 12:45 PM - 1:00 PM Central Time
    Target trial emulation of biologic and targeted synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis-associated interstitial lung disease

    Presenting Author: Gregory McDermott, MD, MPH – Brigham and Women's Hospital